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RESEARCH ARTICLE
RISK FACTOR PROFILES OF ADVERSE 
NEUROMOTOR OUTCOME IN INFANTS
Abstract
Objective
Assessment of risk predictors for adverse neurodevelopmental outcome at 1 
year of age in term and near-term infants.
Material & Methods
This case-control study was a representative sample of infants from different 
health–care centers of north and east of Tehran. The association between 
risk factors and delayed motor development (developmental quotient below 
70 indicating a significant delay) was analyzed using correlating risk factors; 
including the perinatal and neonatal data to the developmental status. The 
case group consisted of 143 infants whose DQ score was less than 70 and the 
control group consisted of 140 infants who had a DQ score of more than 70. 
Results
Neonatal seizures, Apgar score less than 3 after 5 minutes of birth (OR = 2.87 
[95% CI; 1.68, 4.92]), low birth weight (OR = 5.86 [95% CI; 3.07, 11.18]), preterm 
delivery (OR =6.17 [95% CI; 3.04, 12.52]), Premature rupture of membranes 
(PROM)>24 hours (OR = 6.18[95% CI; 2.07, 18.51]) and hyperbilirubinemia 
leading to phototherapy or exchange transfusion (OR =3.75 [95% CI; 2.12, 6.65]) 
were associated with an increased risk for neuromotor delay on developmental 
examination at 1 year.
Conclusion
This study identified distinct risk factors for an adverse outcome in infants. In 
this environment, perinatal risk predictors are most important.
Keywords: Neurodevelopmental outcome, perinatal period, infant, risk factor.
Introduction
According to the American Academy of Pediatrics (AAP), developmental 
disorders, with a prevalence rate of 15-20%, are one of the most common 
problems in pediatrics, and a priority for the American health system (1). In the 
past two decades, due to the rise in the health status of different countries around 
the world, satisfactory vaccination coverage, and widespread use of antibiotics, 
a decrease in infant mortality rates caused by infections has occurred. Advances 
in perinatal and neonatal care produce higher survival rates in high risk infants. 
Increased survival rates, however, are linked to an increased awareness about 
morbidity (2, 3).
According to a WHO report, “perinatal factors “are the fourth most common 
cause of mortality in all ages in Iran and cause 10 years of life lost (YLL), 
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which is the third most common cause for lost years 
in Iran (4). According to the same report, under - 5- 
mortality rate in Iran were 38 per 1000 live births, 
63 percent of which was due to neonatal mortality (in 
comparison with 43 percent for the regional average of 
Eastern Mediterranean countries). When considering 
years of life lost in Iran, one can also presume that 
childhood long–term morbidities and handicaps may 
be significantly related to the perinatal period, as well. 
These disabilities are proposed to be predictable by 
variables describing the perinatal and neonatal period 
(5, 6). 
However, it is often difficult to disentangle effects 
that are attributable to perinatal factors from 
those attributable to other environmental, socio-
demographic or maternal factors that are associated 
with developmental delays (7). 
It is worth noting that since perinatal risk factors, 
including maternal, fetal, neonatal or labor–related 
factors, are affected by health - care conditions in 
every society, which are in turn affected by the socio- 
cultural– economical status, it is important to assess 
and rank risk factors in terms of priority in every 
country, individually. 
The current study was designed to examine the 
associations of perinatal and neonatal factors 
and neuromotor delay at 1 year of age in a 
geographically defined population. Assessment of 
neurodevelopmental performance at the 1 year of 
age, often chosen as an index of short-term outcome 
because major abnormalities, is recognizable at this 
time (8, 9). Previous studies have described early risk 
predictors for an adverse neurological outcome but 
most of them have focused on very preterm babies 
(9-12); therefore, data on near term and term infants, 
who comprise a larger proportion of births, are 
sparse. This study was conducted to characterize risk 
predictors in this population.
Material & Methods
The study was conducted in northern and eastern 
districts of Tehran (the capital city of Iran with 10 
million inhabitants) on 283 infants (2007-2008). 
All one-year-old infants during the study period 
(6 months) who were visited at health-care centers 
for vaccination and routine child care visits were 
examined by general physicians who participated in 
the study. The case group consisted of 143 infants 
whose developmental quotient (DQ) score was less 
than 70, and the control group consisted of 140 infants 
who were visited at the same health-care centers and 
had a DQ score of more than 70.
Those who lacked complete and precise medical 
records regarding perinatal and neonatal stages of life, 
and children with major congenital or chromosomal 
abnormalities, metabolic disorders, neurodegenerative 
encephalopathy, CNS accident or infection were 
excluded. 
Maternal and neonatal data included maternal age, 
timing of the rupture of membranes, mode of delivery, 
history of infertility and related treatments, history 
of medical prescriptions and use during pregnancy, 
multiple pregnancy, birth weight (grams), gestational 
age (full weeks of gestation), sex, neonatal convulsion, 
Apgar score, neonatal respiratory problem, and icterus 
leading to phototherapy or exchange transfusion. 
Also, microcephaly at birth and examination, neonatal 
intensive care unit admission (NICU)> 3 days, auditory 
and visual impairment were evaluated.
Neonatal convulsion in this study was defined as a 
convulsion during the neonatal period based on clinical 
diagnosis of a physician, occurring at least once and 
without metabolic disorders such as hypoglycemia 
or hypocalcaemia, and with no need for long-term 
treatment with anti epileptic drugs; and conversion to 
normal EEG after 2-3 months of treatment. Premature 
rupture of membranes (PROM) was defined as rupture 
of membranes for more than 24 h before delivery. A 
diagnosis of neonatal respiratory problem required 
surfactant treatment or respiratory assisted ventilation. 
A low Apgar score was defined as the score less than 3 
under 5 minutes of birth.
The physician’s visit included an interview with the 
infant’s mother or other primary caregiver, a physical 
and neurological examination (8), assessment of 
neuromotor development using developmental 
quotient (DQ), ascertainment of vision and hearing 
through the caregiver’s report and measurement of 
weight, length and head circumference. Further clinical 
and paraclinical evaluations such as utilization the 
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EEG, CT-Scan, MRI, ABR, metabolic assessments, 
ophthalmologic examination, etc. were carried out 
whenever necessary. 
Developmental quotients calculate from division of 
motor developmental age to infant chronological age 
according to the gross motor Gesell developmental 
scale (1). The mean score was considered 100, and a 
score less than 85 (>1 SD below the mean) indicated a 
delay and a score less than 70 (>2SDs below the mean) 
indicated a significant delay. Neurodevelopmental 
delay (adverse outcome) was defined as a score 
below 70. Patients with cerebral palsy, blindness or 
sensoneural hearing loss requiring hearing aid were 
included in the group of infants with an adverse 
outcome.
According to a previous study on the prevalence of 
infant neuromotor delays performed in Tehran (with 
99% confidence level and 95% statistical power), the 
sample size of the cases and controls was selected 
(13). 
Data analysis was performed using SPSS software 
version 13.0 for windows (SPSS Inc., Chicago, IL, 
USA). Comparison of categorical data was made using 
the chi-square or Fischer’s exact test. The univariate 
risk profile for adverse outcomes was computed using 
means of risk estimates. A significant level of P values 
<0.05 was used in all analyses.
The study was approved by the university ethical 
committee, and in ethical terms, informed consent of 
the parents was acquired for carrying out the test for 
each child. There was no obligation of any kind for 
participating in the study.
Results
During the survey period, a total of 153 one-year-
old children with neuromotor delay were admitted 
and enrolled in the current study. Ten children were 
excluded from analysis because of major congenital 
or chromosomal abnormalities or metabolic diseases. 
Thus, 143 infants were eligible for the case group. 
Fifty one percent of the cases and 50.7% of the 
controls were male.  
Mean gestational age of the infants was 38 weeks and 
mean birth weight was 2910 grams. Table 1&2 depict 
demographic, antenatal and neonatal characteristics 
(history & physical examination findings) of the 
participants. As seen in Table 1, there were non-
significant socio-demographic differences between 
two groups. 
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Table1: Demographic characteristics of the case and control groups
P ValueControl GroupCase GroupVariable
n.s.35±13 €33±13 €Chronological Age(weeks)
n.s.26±5 €27±5 €Maternal age (years)
0.00139.6±1€ 37±4 €Gestational Age(weeks)
0.0013131±498 €2689±851 €Birth Weight(grams)
n.s.71(50.7)73(51)Male Number (%)
€ Mean ±Standard Deviation
N.S = not significant
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Perinatal and neonatal  factors (including neonatal 
convulsion, a low Apgar score, meconium– stained 
amniotic fluid, low birth weight (LBW), very low birth 
weight (VLBW), gestational age<37 weeks, neonatal 
respiratory problems, hyperbillirubinemia), and maternal 
factors (including premature rupture of membranes, 
history of infertility and related treatments, and history 
of medical prescriptions and use during pregnancy) were 
significantly related with a lower developmental quotient 
(P Value < 0.05).
Table2: Perinatal and neonatal characteristics of the 
















0.0010/14016/143Infertility history and related treatments






0.0010/14045/143NICU β admissions >3 days
*Low Birth Weight
**Very Low Birth Weight
*** Icterus leading to phototherapy or exchange transfusion
****Premature Rupture of Membrane
β Neonatal Intensive Care Unit
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Also, microcephaly, neonatal intensive care unit 
admission (NICU) > 3 days, and auditory and visual 
impairment were significantly related with a lower 
developmental quotient (P Value < 0.05), but multiple 
gestations had a border-line p-value (P=0.06).  
Table 3 depicts candidate risk factors [a higher Odds 
Ratio with a narrow Confidence Interval (OR; [95% 
CI)] associated with adverse outcomes in two groups. 
Discussion
Brain development includes growth and differentiation 
on a cellular as well as a biochemical level during 
gestation. Potential risk factors for an adverse 
neurodevelopmental outcome may cause different 
effects on the developing brain at different gestational 
ages. In the current study, we assessed separate risk 
profiles for the neuromotor delay at 12 months age in 
two groups, and the following factors were found to 
have an association with neuromotor delay: neonatal 
convulsion, a low Apgar score, premature birth, LBW, 
PROM and icterus leading to phototherapy or exchange 
transfusion.
An important predictor for adverse motor outcomes 
was neonatal seizures. Neonatal seizures without 
metabolic problems can be considered as an indicator 
of hypoxic-ischemic brain injury. Recent evidence 
has raised concerns that both seizures and certain 
medications used in their treatment result in increased 
risk of neurologic mortality and morbidity (14). Some 
studies have shown that mortality may be as high as 
30% of newborns with neonatal seizures and that more 
than 50% have significant neurologic and cognitive 
disorders (15). 
An Apgar score less than 3 at 5 minutes after birth also 
emerged as a risk predictor (OR = 2.87 [95% CI; 1.68, 
4.92]), which is comparable to the results of many other 
studies (13, 16-17). Among all etiologies for neonatal 
mortality in Iran, birth asphyxia (22%) is a one of the 
most common (4). Also in developing countries, among 
all etiologies of cerebral palsy, birth asphyxia (25-30%) 
is one of the most common causes (18).  
Low birth weight (OR = 5.86 [95% CI; 3.07, 
11.18]) was associated with a significantly poor 
neuromotor outcome in this study. Permanent neuro-
developmental problems occurred 2 to 5 times more 
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Complication in the neonatal period are inversely 
related to gestational age and are therefore less frequent 
in the term group and, if present, do not account for 
a significant risk of adverse neurological outcomes in 
the majority of cases. In our study, gestational ages 
<37 weeks (OR =6.17 [95% CI; 3.04, 12.52]) was 
associated with neuromotor delay.
Due to shortage of experts and properly- equipped 
NICUs in Iran, the premature infants’ survival rate is 
lower than western countries and adverse outcomes are 
higher. Also, we must consider the higher incidence of 
other risk factors that are associated with prematurity, 
such as a long period of hospitalization, neonatal 
respiratory problems and NICU admission (25). In our 
study, NICU admission, regardless of the diagnosis, 
showed a significant association with developmental 
delay. 
Apart from asphyxia and LBW, PROM>24 hours 
(OR = 6.18[95% CI; 2.07, 18.51]) was found to 
be an independent risk predictor for an adverse 
outcome. PROM is frequently caused by intrauterine 
infection. Infection results in a systemic inflammatory 
response eliciting the production of a wide array of 
proinflammatory mediators that can injure the fetal 
central nervous system (26).
Differentiation of grey and white matter and 
myelinataion significantly increases with gestational 
age (27). Inflammatory stress may therefore also affect 
brain maturation at later stages of brain development 
resulting in neurodevelopmental adverse outcomes.
In this study, neuromotor delays were significantly 
correlated with hyperbilirubinemia leading to 
Table3: Association between candidate risk variables and

















**Icterus leading to phototherapy or exchange transfusion
***Premature Rupture of Membrane
€ Not applicable; Odds ratio and confidence limit cannot be calculated due to zero cells.
frequently in LBW compared to normal birth weight 
infants (19). As a group, their prevalence increases 
with decreasing birth weight and gestational age (20, 
21). Studies investigating the neurodevelopmental 
outcome of infants born small for gestational age 
(SGA) as compared with those born appropriate for 
gestational age (AGA) have reported controversial 
results (22- 24).
One of our limitations was that the exact gestational 
age of many infants was unclear in our study because 
many mothers lacked on ultrasound report during 
pregnancy, which made it further difficult to ascertain 
AGA or SGA conditions in many neonates. 
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phototherapy or exchange transfusion (OR =3.75 
[95% CI; 2.12, 6.65]).
We cannot ignore the possibility of the co-existence 
of other environmental risk factors such as the process 
of providing care and therapy for the icteric newborns 
with this association. Currently, there are no bilirubin 
binding tests in routine clinical use in Iran, as is true 
in the majority of other countries.
One of our limitations was that neuromotor outcomes 
were assessed in a single visit at 1 year of age. It is difficult 
to determine whether some of the problems identified 
are transient or reflect persistent impairment. Long-term 
follow-ups with repeated visits are necessary to determine 
the final outcome.
In conclusion,Obviously, one must keep in mind the 
synergic effects of different co-existing risk factors as well 
as the counteracting effect of risk factors and protective 
factors, the overall interaction of which determines the 
final outcome.
We suggest that the above-mentioned significantly 
correlating factors be considered as important and valuable 
clues by Iranian physicians and those in other developing 
countries such as Iran, to evaluate affected newborns in 
order to detect any subtle signs of neurodevelopmental 
delay as early as possible.
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